Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to identify the most optimal therapy for Bowen's disease: excision versus Photodynamic therapy.


Clinical Trial Description

The study is a randomized clinical trial in which two treatment options for Bowen's disease, excision and photodynamic therapy, are compared on recurrence rate, cosmesis en expenses. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00472706
Study type Interventional
Source Catharina Ziekenhuis Eindhoven
Contact
Status Terminated
Phase Phase 4
Start date May 2007
Completion date February 2010

See also
  Status Clinical Trial Phase
Completed NCT03012009 - Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial N/A
Completed NCT03320447 - Long-term Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy for Treatment of Lower Extremity Bowen's Disease Phase 1
Completed NCT02085395 - Clinical Study Assessment of SR-T100 Topical Gel Against Actinic Keratosis Phase 2
Recruiting NCT03909646 - Surgical Excision Versus Photodynamic Therapy and Topical 5-fluorouracil in Treatment of Bowen's Disease Phase 4
Completed NCT04293679 - Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With isSCC Phase 1/Phase 2
Completed NCT01912976 - Study of Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Laser in Bowen's Disease Phase 1
Active, not recruiting NCT06014697 - OCT and Invasion in Cutaneous Skin Lesions
Completed NCT03167762 - Photographing the Skin During Photodynamic Therapy N/A
Recruiting NCT02759900 - Using a Cold Atmospheric Plasma Device to Treat Skin Disorders N/A
Recruiting NCT05402046 - Clinical vAlidation of a MobilE appLication ("ProRodinki") in the Assessment of the maLignant skIn neoplAsms N/A
No longer available NCT00535080 - Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's Disease